Genetic Association Studies in Drug-Induced Liver Injury

被引:70
作者
Daly, Ann K. [1 ]
Day, Chris P. [1 ]
机构
[1] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
Human leukocyte antigen; genome-wide association; candidate-gene; N-acetyltransferase; 2; single nucleotide polymorphism; S-TRANSFERASE M1; INDUCED HEPATOTOXICITY; GENOMEWIDE ASSOCIATION; RISK-FACTOR; POLYMORPHISMS; SUSCEPTIBILITY; GENOTYPE; HLA; PHARMACOGENETICS; STRATIFICATION;
D O I
10.1055/s-0029-1240009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Genetic studies on drug-Induced liver injury (DILI) have proved challenging, both because of their rarity and their difficulty in replicating observed effects. However, significant progress has now been achieved by both candidate-gene and genome-wide association studies. These two approaches are considered in detail, together with examples of DILI due to specific drugs where consistent associations have been reported. particular consideration is given to associations between antituberculosis drug-related liver injury and the "slow acetylator" genotype for N-acetyltransferase 2, amoxicillin/clavulanate-related liver injury, and the human leukocyte antigen (HLA) class II DRB1*1501 allele and flucloxacillin-related injury and the HLA class I B*5701 allele. Although these associations are drug-specific, the possibility that additional, more general susceptibility genes for DILI exist requires further investigation, ideally by genome-wide association studies involving international collaboration. The possibility of interethnic variation in susceptibility to DILI also requires further study.
引用
收藏
页码:400 / 411
页数:12
相关论文
共 77 条
[1]   Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity [J].
Acuña G. ;
Foernzler D. ;
Leong D. ;
Rabbia M. ;
Smit R. ;
Dorflinger E. ;
Gasser R. ;
Hoh J. ;
Ott J. ;
Borroni E. ;
To Z. ;
Thompson A. ;
Li J. ;
Hashimoto L. ;
Lindpaintner K. .
The Pharmacogenomics Journal, 2002, 2 (5) :327-334
[2]   Promoter polymorphisms of interleukin-10 (IL-10) and interleukin-4 (IL-4) predict the risk of diclofenac-induced hepatotoxicity. [J].
Aithal, GP ;
Daly, AK ;
Leathart, J ;
Yuanneng, CP ;
Day, CP .
GASTROENTEROLOGY, 2000, 118 (04) :A977-A977
[3]   Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity [J].
Aithal, GP ;
Ramsay, L ;
Daly, AK ;
Sonhit, N ;
Leathart, JBS ;
Alexander, G ;
Kenna, JG ;
Caldwell, J ;
Day, CP .
HEPATOLOGY, 2004, 39 (05) :1430-1440
[4]   A haplotype map of the human genome [J].
Altshuler, D ;
Brooks, LD ;
Chakravarti, A ;
Collins, FS ;
Daly, MJ ;
Donnelly, P ;
Gibbs, RA ;
Belmont, JW ;
Boudreau, A ;
Leal, SM ;
Hardenbol, P ;
Pasternak, S ;
Wheeler, DA ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Zeng, CQ ;
Gao, Y ;
Hu, HR ;
Hu, WT ;
Li, CH ;
Lin, W ;
Liu, SQ ;
Pan, H ;
Tang, XL ;
Wang, J ;
Wang, W ;
Yu, J ;
Zhang, B ;
Zhang, QR ;
Zhao, HB ;
Zhao, H ;
Zhou, J ;
Gabriel, SB ;
Barry, R ;
Blumenstiel, B ;
Camargo, A ;
Defelice, M ;
Faggart, M ;
Goyette, M ;
Gupta, S ;
Moore, J ;
Nguyen, H ;
Onofrio, RC ;
Parkin, M ;
Roy, J ;
Stahl, E ;
Winchester, E ;
Ziaugra, L ;
Shen, Y .
NATURE, 2005, 437 (7063) :1299-1320
[5]   Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[6]   HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease [J].
Andrade, RJ ;
Lucena, MI ;
Alonso, A ;
García-Cortes, M ;
García-Ruiz, E ;
Benitez, R ;
Fernández, MC ;
Pelaez, G ;
Romero, M ;
Corpas, R ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Nogueras, F ;
Martín-Vivaldi, R ;
Navarro, JM ;
Salmerón, J ;
de la Cuesta, FS ;
Hidalgo, R .
HEPATOLOGY, 2004, 39 (06) :1603-1612
[7]   POSSIBLE ROLE OF HLA IN HEPATOTOXICITY - AN EXPLORATORY-STUDY IN 71 PATIENTS WITH DRUG-INDUCED IDIOSYNCRATIC HEPATITIS [J].
BERSON, A ;
FRENEAUX, E ;
LARREY, D ;
LEPAGE, V ;
DOUAY, C ;
MALLET, C ;
FROMENTRY, B ;
BENHAMOU, JP ;
PESSAYRE, D .
JOURNAL OF HEPATOLOGY, 1994, 20 (03) :336-342
[8]   Genetic variants of hepatic transporters and susceptibility to drug induced liver injury [J].
Bhatnagar, Pallav ;
Day, Chris P. ;
Aithal, Guruprasad ;
Pirmohamed, Munir ;
Bernal, William ;
Daly, Ann K. .
TOXICOLOGY, 2008, 253 (1-3) :10-10
[9]   Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden [J].
Björnsson, E ;
Jerlstad, P ;
Bergqvist, A ;
Olsson, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (09) :1095-1101
[10]   Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity [J].
Boelsterli, UA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 192 (03) :307-322